Drug shortages

Fosaprepitant Dimeglumine Injection

Fresenius Kabi USA, LLC

To Be Discontinued63323-972-10Gastroenterology
Open FDA's page for this record
Discontinued date
04/08/2026
Update type
New
Initial posting date
04/08/2026
Package NDC
63323-972-10
Generic name
Fosaprepitant Dimeglumine Injection
Contact info
888-386-1300
Related info
Discontinuation of the manufacture of the drug
Update date
04/08/2026
Dosage form
Injection
Presentation
Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)
Company name
Fresenius Kabi USA, LLC
Status
To Be Discontinued
Therapeutic category
Gastroenterology
Harmonized identifiers (openFDA)
Application number
ANDA206197
Brand name
FOSAPREPITANT
Generic name
FOSAPREPITANT
Manufacturer name
Fresenius Kabi USA, LLC
Product NDC
63323-972
Product type
HUMAN PRESCRIPTION DRUG
Route
INTRAVENOUS
Substance name
FOSAPREPITANT DIMEGLUMINE
RxCUI
1731077
SPL ID
864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c
SPL set ID
ffee61d1-c1c6-4224-871c-ab7ff6cd01e5
Package NDC
63323-972-10
UNII
D35FM8T64X
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.